Mitochondrial disorders as windows into an ancient organelle

Nature

Volumn 491, Issue 7424, 2012, Pages 374-383

  Vafai, Scott B ^a,b   Mootha, Vamsi K ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

GENETICS; MITOCHONDRIAL DNA; PATHOGENICITY; RESPIRATORY DISEASE;

BRAIN DISEASE; CELL ORGANELLE; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENVIRONMENTAL FACTOR; EPILEPSY; GENETICS; HEARING IMPAIRMENT; HUMAN; INTESTINE OBSTRUCTION; KIDNEY FAILURE; LEIGH DISEASE; LIVER FAILURE; MUSCLE WEAKNESS; MUTATION; OPTIC NERVE DISEASE; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW; SEIZURE;

BIOLOGICAL EVOLUTION; ELECTRON TRANSPORT; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES;

EID: 84869051280     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11707     Document Type: Review

References (98)

1. Ernster, L., Ikkos, D. & Luft, R. Enzymic activities of human skeletal muscle mitochondria: a tool in clinical metabolic research. Nature 184, 1851-1854 (1959).
2. DiMauro, S. et al. Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J. Neurol. Sci. 27, 217-232 (1976).
3. Skladal, D., Halliday, J. & Thorburn, D. R. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126, 1905-1912 (2003).
4. Munnich, A., Rotig, A., Cormier-Daire, V. & Rustin, P. in Scriver's Online Metabolic and Molecular Basis of Inherited Disease (eds Valle, D. et al.) Ch. 99 http://dx.doi.org/10.1036/ommbid.127 (McGraw-Hill, 2006)
5. Shoffner, J. in Scriver's Online Metabolic and Molecular Basis of Inherited Disease (eds Valle, D. et al.) Ch. 104 http://dx.doi.org/10.1036/ ommbid.127 (McGraw-Hill, 2006).
6. McKenzie, R. et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N. Engl. J. Med. 333, 1099-1105 (1995).
7. Pagliarini, D. J. et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112-123 (2008).
8. Andersson, S. G. et al. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396, 133-140 (1998).
9. Szklarczyk, R. & Huynen, M. A. Mosaic origin of the mitochondrial proteome. Proteomics 10, 4012-4024 (2010).
10. Sharma, M. R. et al. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell 115, 97-108 (2003).
11. Shutt, T. E. & Gray, M. W. Bacteriophage origins of mitochondrial replication and transcription proteins. Trends Genet. 22, 90-95 (2006).
12. Bourdon, A. et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nature Genet. 39, 776-780 (2007).
13. Tibbetts, A. S. & Appling, D. R. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 30, 57-81 (2010).
14. Jain, M. et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336, 1040-1044 (2012).
15. Hackenbrock, C. R., Chazotte, B. & Gupte, S. S. The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport. J. Bioenerg. Biomembr. 18, 331-368 (1986).
16. Chance, B. & Williams, G. R. A method for the localization of sites for oxidative phosphorylation. Nature 176, 250-254 (1955).
17. Schagger, H. & Pfeiffer, K. The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J. Biol. Chem. 276, 37861-37867 (2001).
18. Schagger, H. & von Jagow, G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem. 199, 223-231 (1991).
19. Cruciat, C. M., Brunner, S., Baumann, F., Neupert, W. & Stuart, R. A. The cytochrome bc1 and cytochrome c oxidase complexes associate to form a single supracomplex in yeast mitochondria. J. Biol. Chem. 275, 18093-18098 (2000).
20. Shoubridge, E. A. Supersizing the mitochondrial respiratory chain. Cell Metab. 15, 271-272 (2012).
21. Efremov, R. G., Baradaran, R. & Sazanov, L. A. The architecture of respiratory complex I. Nature 465, 441-445 (2010).
22. Hunte, C., Zickermann, V. & Brandt, U. Functional modules and structural basis of conformational coupling in mitochondrial complex I. Science 329, 448-451 (2010).
23. Runswick, M. J., Fearnley, I. M., Skehel, J. M. & Walker, J. E. Presence of an acyl carrier protein in NADH:ubiquinone oxidoreductase from bovine heart mitochondria. FEBS Lett. 286, 121-124 (1991).
24. Nouws, J. et al. Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab. 12, 283-294 (2010).
25. Cogswell, A. M., Stevens, R. J. & Hood, D. A. Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am. J. Physiol. 264, C383-C389 (1993).
26. Fannin, S. W., Lesnefsky, E. J., Slabe, T. J., Hassan, M. O. & Hoppel, C. L. Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch. Biochem. Biophys. 372, 399-407 (1999).
27. Allen, J. F. The function of genomes in bioenergetic organelles. Phil. Trans. R. Soc. Lond. B 358, 19-37 (2003).
28. Johnson, D. T., Harris, R. A., Blair, P. V. & Balaban, R. S. Functional consequences of mitochondrial proteome heterogeneity. Am. J. Physiol. Cell Physiol. 292, C698-C707 (2007).
29. Pierron, D. et al. Cytochrome c oxidase: evolution of control via nuclear subunit addition. Biochim. Biophys. Acta 1817, 590-597 (2012).
30. Scarpulla, R. C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813, 1269-1278 (2011).
31. Spiegelman, B. M. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found. Symp. 287, 60-63 (2007).
32. MacAskill, A. F. & Kittler, J. T. Control of mitochondrial transport and localization in neurons. Trends Cell Biol. 20, 102-112 (2010).
33. Chan, D. C. Fusion and fission: interlinked processes critical for mitochondrial health. Annu. Rev. Genet. http://dx.doi.org/10.1146/annurev-genet- 110410-132529 (29 August, 2012).
34. Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nature Rev. Mol. Cell Biol. 12, 9-14 (2011).
35. Balaban, R. S., Kantor, H. L., Katz, L. A. & Briggs, R. W. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 232, 1121-1123 (1986).
36. Chance, B. & Williams, G. R. Respiratory enzymes in oxidative phosphorylation. III. The steady state. J. Biol. Chem. 217, 409-427 (1955).
37. Glancy, B. & Balaban, R. S. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry 51, 2959-2973 (2012).
38. Kacser, H. & Burns, J. A. The control of flux. Symp. Soc. Exp. Biol. 27, 65-104 (1973).
39. Heinrich, R. & Rapoport, T. A. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. Eur. J. Biochem. 42, 89-95 (1974).
40. Groen, A. K., Wanders, R. J., Westerhoff, H. V., van der Meer, R. & Tager, J. M. Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257, 2754-2757 (1982).
41. Hartwell, L. Genetics. Robust interactions. Science 303, 774-775 (2004).
42. Rossignol, R., Malgat, M., Mazat, J. P. & Letellier, T. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J. Biol. Chem. 274, 33426-33432 (1999).
43. Anderson, S. et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457-465 (1981).
44. Wallace, D. C. et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242, 1427-1430 (1988).
45. Holt, I. J., Harding, A. E. & Morgan-Hughes, J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331, 717-719 (1988).
46. Bourgeron, T. et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nature Genet. 11, 144-149 (1995).
47. Calvo, S. E. & Mootha, V. K. The mitochondrial proteome and human disease. Annu. Rev. Genomics Hum. Genet. 11, 25-44 (2010).
48. Koopman, W. J., Willems, P. H. & Smeitink, J. A. Monogenic mitochondrial disorders. N. Engl. J. Med. 366, 1132-1141 (2012).
49. Park, S. G., Schimmel, P. & Kim, S. Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl Acad. Sci. USA 105, 11043-11049 (2008).
50. Nishino, I., Spinazzola, A. & Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283, 689-692 (1999).
51. Lieber, D. S. et al. Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Med. Genet. 13, 3 (2012).
52. Kornmann, B. et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science 325, 477-481 (2009).
53. Hobbs, A. E., Srinivasan, M., McCaffery, J. M. & Jensen, R. E. Mmm1p, a mitochondrial outer membrane protein, is connected to mitochondrial DNA (mtDNA) nucleoids and required for mtDNA stability. J. Cell Biol. 152, 401-410 (2001).
54. Kirkman, M. A. et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 132, 2317-2326 (2009).
55. Sadun, A. Acquired mitochondrial impairment as a cause of optic nerve disease. Trans. Am. Ophthalmol. Soc. 96, 881-923 (1998).
56. Bitner-Glindzicz, M. et al. Prevalence of mitochondrial 1555A>G mutation in European children. N. Engl. J. Med. 360, 640-642 (2009).
57. Prezant, T. R. et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet. 4, 289-294 (1993).
58. Cote, H. C. et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N. Engl. J. Med. 346, 811-820 (2002).
59. Viscomi, C. et al. Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nature Med. 16, 869-871 (2010).
60. Reeves, M. B., Davies, A. A., McSharry, B. P., Wilkinson, G. W. & Sinclair, J. H. Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 316, 1345-1348 (2007).
61. Vasta, V., Merritt, J. L. 2nd, Saneto, R. P. & Hahn, S. H. Next-generation sequencing for mitochondrial diseases reveals wide diagnostic spectrum. Pediatr. Int. 54, 585-601 (2012).
62. Calvo, S. E. et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci. Transl. Med. 4, 118ra110 (2012).
63. Vockley, J., Rinaldo, P., Bennett, M. J., Matern, D. & Vladutiu, G. D. Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol. Genet. Metab. 71, 10-18 (2000).
64. Guan, M. X. et al. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am. J. Hum. Genet. 79, 291-302 (2006).
65. von Kleist-Retzow, J. C. et al. Impaired mitochondrial Ca2+ homeostasis in respiratory chain-deficient cells but efficient compensation of energetic disadvantage by enhanced anaerobic glycolysis due to low ATP steady state levels. Exp. Cell Res. 313, 3076-3089 (2007).
66. Trifunovic, A. et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc. Natl Acad. Sci. USA 102, 17993-17998 (2005).
67. Kujoth, G. C. et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-484 (2005).
68. Butow, R. A. & Avadhani, N. G. Mitochondrial signaling: the retrograde response. Mol. Cell 14, 1-15 (2004).
69. Miceli, M. V., Jiang, J. C., Tiwari, A., Rodriguez-Quinones, J. F. & Jazwinski, S. M. Loss of mitochondrial membrane potential triggers the retrograde response extending yeast replicative lifespan. Front. Genet. 2, 102 (2011).
70. Owusu-Ansah, E., Yavari, A., Mandal, S. & Banerjee, U. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nature Genet. 40, 356-361 (2008).
71. Mandal, S., Guptan, P., Owusu-Ansah, E. & Banerjee, U. Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila. Dev. Cell 9, 843-854 (2005).
72. Haynes, C. M. & Ron, D. The mitochondrial UPR - protecting organelle protein homeostasis. J. Cell Sci. 123, 3849-3855 (2010).
73. Rugarli, E. I. & Langer, T. Mitochondrial quality control: a matter of life and death for neurons. EMBO J. 31, 1336-1349 (2012).
74. Shaham, O. et al. A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc. Natl Acad. Sci. USA 107, 1571-1575 (2010).
75. Morais, R., Guertin, D. & Kornblatt, J. A. On the contribution of the mitochondrial genome to the growth of Chinese hamster embryo cells in culture. Can. J. Biochem. 60, 290-294 (1982).
76. Mullen, A. R. et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481, 385-388 (2012).
77. Perocchi, F. et al. MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake. Nature 467, 291-296 (2010).
78. Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341-345 (2011).
79. De Stefani, D., Raffaello, A., Teardo, E., Szabo, I. & Rizzuto, R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336-340 (2011).
80. Biswas, G. et al. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 18, 522-533 (1999).
81. Arnould, T. et al. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J. 21, 53-63 (2002).
82. Wu, H. et al. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296, 349-352 (2002).
83. Molkentin, J. D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
84. Ward, S. M. et al. Pacemaking in interstitial cells of Cajal depends upon calcium handling by endoplasmic reticulum and mitochondria. J. Physiol. 525, 355-361 (2000).
85. Brini, M. et al. A calcium signalling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nature Med. 5, 951-954 (1999).
86. Kaftan, E. J., Xu, T., Abercrombie, R. F. & Hille, B. Mitochondria shape hormonally induced cytoplasmic calcium oscillations and modulate exocytosis. J. Biol. Chem. 275, 25465-25470 (2000).
87. Suomalainen, A. et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806-818 (2011).
88. West, A. P., Shadel, G. S. & Ghosh, S. Mitochondria in innate immune responses. Nature Rev. Immunol. 11, 389-402 (2011).
89. Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D. & Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. 4, CD004426 (2012).
90. Hoppins, S. et al. A mitochondrial-focused genetic interaction map reveals a scaffold-like complex required for inner membrane organization in mitochondria. J. Cell Biol. 195, 323-340 (2011).
91. Nilsson, R. et al. Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis. Cell Metab. 10, 119-130 (2009).
92. Stacpoole, P. W. Why are there no proven therapies for genetic mitochondrial diseases? Mitochondrion 11, 679-685 (2011).
93. Michelakis, E. D. et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med. 2, 31ra34 (2010).
94. Kirby, D. M. & Thorburn, D. R. Approaches to finding the molecular basis of mitochondrial oxidative phosphorylation disorders. Twin Res. Hum. Genet. 11, 395-411 (2008).
95. Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614 (2000).
96. Gohil, V. M. et al. Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nature Biotechnol. 28, 249-255 (2010).
97. Copeland, J. M. et al. Extension of Drosophila life span by RNAi of the mitochondrial respiratory chain. Curr. Biol. 19, 1591-1598 (2009).
98. Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet. 33, 40-48 (2003).